Skip to content
RecallWatchMedical Device Safety
Device type

Alternate Controller Enabled Insulin Infusion Pump recalls

The FDA has posted 14 enforcement recalls of alternate controller enabled insulin infusion pump devices since 2025, including 6 Class I (most serious) recalls. Most recent report: Jul 8, 2026.

Class I: 6Class II: 8

Who is recalling these devices

Class IIOngoingZ-2513-2026

Beta Bionics, Inc. recalls iLet Bionic Pancreas

The reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock…

  • Alternate Controller Enabled Insulin Infusion Pump
  • Software design
Beta Bionics, Inc.CAJun 24, 2026
Class IIOngoingZ-1996-2026

Beta Bionics, Inc. recalls iLet Bionic Pancreas

insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses…

  • Alternate Controller Enabled Insulin Infusion Pump
  • Software change control
Beta Bionics, Inc.CAMay 6, 2026
Class IIOngoingZ-1809-2026

Beta Bionics, Inc. recalls iLet Ace Pump Kit REF: BB1001 iLet Dosing Decision Software

it was found that in versions 1.3.7, 1.4.2, and 1.4.3, the Lock Screen and Limited Access Passcode Screen on the iLet graphical user interface (GUI) include certain icons displayed in the status bar that are active, ther…

  • Alternate Controller Enabled Insulin Infusion Pump
  • Software design
Beta Bionics, Inc.CAApr 22, 2026
Class IIOngoingZ-1741-2026

Medtronic MiniMed, Inc. recalls MiniMed 780G Insulin Pump (MMT-1884

All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infu…

  • Alternate Controller Enabled Insulin Infusion Pump
  • Device Design
Medtronic MiniMed, Inc…CAApr 8, 2026
Class IIOngoingZ-0232-2026

Tandem Diabetes Care, Inc. recalls t:slim X2 insulin pump with Interoperable Technology

A software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an unexpec…

  • Alternate Controller Enabled Insulin Infusion Pump
  • Software change control
Tandem Diabetes Care,…CAOct 29, 2025
Class IOngoingZ-2343-2025

Tandem Diabetes Care, Inc. recalls Battery Operated infusion pumps. t:slim X2 G5

Insulin pumps manufactured with speakers from Revision A and B may malfunction ("Malfunction 16") which prevents audible alerts and causes the pumps to become inoperable and stop infusing insulin which could result in a…

  • Alternate Controller Enabled Insulin Infusion Pump
  • Nonconforming Material/Component
Tandem Diabetes Care,…CASep 3, 2025

Source: U.S. FDA openFDA device enforcement reports, updated continuously. Device type per the FDA's RES classification (“Alternate Controller Enabled Insulin Infusion Pump”). Informational only — verify against the FDA before acting.